The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Targeting death receptors in cancer with Apo2L/TRAIL
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Identification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
Self-citationInduction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., & Ashkenazi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12687 · Cited by 1,793
Apo2L/TRAIL and its death and decoy receptors
LeBlanc, H. N., & Ashkenazi, A. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401187 · Cited by 854
Jo, M., Kim, T.-H., Seol, D.-W., Esplen, J. E., Dorko, K., Billiar, T. R., & Strom, S. C. (2000) · Nature Medicine · doi:10.1038/75045 · Cited by 843
Takeda, K., Hayakawa, Y., Smyth, M. J., Kayagaki, N., Yamaguchi, N., Kakuta, S., Iwakura, Y., Yagita, H., & Okumura, K. (2001) · Nature Medicine · doi:10.1038/83416 · Cited by 775
Fulda, S., Wick, W., Weller, M., & Debatin, K.-M. (2002) · Nature Medicine · doi:10.1038/nm735 · Cited by 741
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
Lawrence, D., Shahrokh, Z., Marsters, S., Achilles, K., Shih, D., Mounho, B., Hillan, K., Totpal, K., DeForge, L., Schow, P., et al. (2001) · Nature Medicine · doi:10.1038/86397 · Cited by 702
Self-citationCretney, E., Takeda, K., Yagita, H., Glaccum, M., Peschon, J. J., & Smyth, M. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1356 · Cited by 616
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy
Almasan, A., & Ashkenazi, A. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00029-7 · Cited by 553
Chinnaiyan, A. M., Prasad, U., Shankar, S., Hamstra, D. A., Shanaiah, M., Chenevert, T. L., Ross, B. D., & Rehemtulla, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030545097 · Cited by 530
Inhibition of Fas death signals by FLIPs
Tschopp, J., Irmler, M., & Thome, M. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80223-9 · Cited by 520
LeBlanc, H., Lawrence, D., Varfolomeev, E., Totpal, K., Morlan, J., Schow, P., Fong, S., Schwall, R., Sinicropi, D., & Ashkenazi, A. (2002) · Nature Medicine · doi:10.1038/nm0302-274 · Cited by 507
TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO
Deng, Y., Lin, Y., & Wu, X. (2002) · Genes & Development · doi:10.1101/gad.949602 · Cited by 458
Kelley, S. K., Harris, L. A., Xie, D., DeForge, L., Totpal, K., Bussiere, J., & Fox, J. A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29298-3 · Cited by 445
Self-citationMitsiades, C. S., Treon, S. P., Mitsiades, N., Shima, Y., Richardson, P., Schlossman, R., Hideshima, T., & Anderson, K. C. (2001) · Blood · doi:10.1182/blood.v98.3.795 · Cited by 392
Nature's TRAIL—On a Path to Cancer Immunotherapy
Smyth, M. J., Takeda, K., Hayakawa, Y., Peschon, J. J., van den Brink, M. R. M., & Yagita, H. (2003) · Immunity · doi:10.1016/s1074-7613(02)00502-2 · Cited by 366
Song, K., Chen, Y., Göke, R., Wilmen, A., Seidel, C., Göke, A., Hilliard, B., & Chen, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1095 · Cited by 359
Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL−/− mice
Lamhamedi-Cherradi, S.-E., Zheng, S.-J., Maguschak, K. A., Peschon, J., & Chen, Y. H. (2003) · Nature Immunology · doi:10.1038/ni894 · Cited by 348
Proteasome-mediated Degradation of Smac during Apoptosis: XIAP Promotes Smac Ubiquitination in Vitro
MacFarlane, M., Merrison, W., Bratton, S. B., & Cohen, G. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200317200 · Cited by 301
A Unique Zinc-Binding Site Revealed by a High-Resolution X-ray Structure of Homotrimeric Apo2L/TRAIL
Hymowitz, S. G., O'Connell, M. P., Ultsch, M. H., Hurst, A., Totpal, K., Ashkenazi, A., de Vos, A. M., & Kelley, R. F. (2000) · Biochemistry · doi:10.1021/bi992242l · Cited by 261
Gliniak, B., & Le, T. (1999) · PubMed · Cited by 261
Roth, W., Isenmann, S., Naumann, U., Kügler, S., Bähr, M., Dichgans, J., Ashkenazi, A., & Weller, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1693 · Cited by 208
Salvesen, G. S. (2002) · Essays in Biochemistry · doi:10.1042/bse0380009 · Cited by 204
Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis
Hilliard, B., Wilmen, A., Seidel, C., Liu, T.-S. T., Göke, R., & Chen, Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1314 · Cited by 198
Naka, T., Sugamura, K., Hylander, B. L., Widmer, M. B., Rustum, Y. M., & Repasky, E. A. (2002) · PubMed · Cited by 190
Cysteine 230 Is Essential for the Structure and Activity of the Cytotoxic Ligand TRAIL
Bodmer, J.-L., Meier, P. F., Tschopp, J., & Schneider, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909721199 · Cited by 182
Schneider, P., Olson, D. L., Tardivel, A., Browning, B., Lugovskoy, A. A., Gong, D., Dobles, M., Hertig, S., Hofmann, K., van Vlijmen, H., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210783200 · Cited by 155
Involvement of TRAIL and its receptors in viral hepatitis
Mundt, B., Kühnel, F., Zender, L., Paul, Y., Tillmann, H. L., Trautwein, C., Manns, M. P., & Kubicka, S. (2002) · The FASEB Journal · doi:10.1096/fj.02-0537fje · Cited by 152
Ravi, R. K., & Bedi, A. (2002) · PubMed · Cited by 145
Kotelkin, A., Prikhod’ko, E. A., Cohen, J. I., Collins, P. L., & Bukreyev, A. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.17.9156-9172.2003 · Cited by 138
Pollack, I. F., Erff, M., & Ashkenazi, A. (2001) · PubMed · Cited by 137
Shigeno, M., Nakao, K., Ichikawa, T., Suzuki, K., Kawakami, A., Abiru, S., Miyazoe, S., Nakagawa, Y., Ishikawa, H., Hamasaki, K., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206139 · Cited by 134
Ray, S., & Almasan, A. (2003) · PubMed · Cited by 115
Tollefson, A. E., Tóth, K., Doronin, K., Kuppuswamy, M. N., Doronina, O. A., Lichtenstein, D. L., Hermiston, T. W., Smith, C. A., & Wold, W. S. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.8875-8887.2001 · Cited by 114
Avoiding premature apoptosis of normal epidermal cells
Qin, J., Chaturvedi, V., Bonish, B. K., & Nickoloff, B. J. (2001) · Nature Medicine · doi:10.1038/86401 · Cited by 106
Totzke, G., Schulze‐Osthoff, K., & Jänicke, R. U. (2003) · Oncogene · doi:10.1038/sj.onc.1206837 · Cited by 100
Leverkus, M., Walczak, H., McLellan, A. D., Fries, H.-W., Terbeck, G., Bröcker, E., & Kämpgen, E. (2000) · Blood · doi:10.1182/blood.v96.7.2628 · Cited by 95
Bouralexis, S., Findlay, D. M., Atkins, G. J., Labrinidis, A., Hay, S. J., & Evdokiou, A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601021 · Cited by 80
Normal Thymocyte Negative Selection in TRAIL-deficient Mice
Cretney, E., Uldrich, A. P., Berzins, S. P., Strasser, A., Godfrey, D. I., & Smyth, M. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030634 · Cited by 72
Macrophages From Cancer Patients: Analysis of TRAIL, TRAIL Receptors, and Colon Tumor Cell Apoptosis
Herbeuval, J., Lambert, C., Sabido, O., Cottier, M., Fournel, P., Dy, M., & Genin, C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.8.611 · Cited by 65
Ramp, U., Caliskan, E., Mahotka, C., Krieg, A. H., Heikaus, S., Gabbert, H. E., & Gerharz, C. D. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600984 · Cited by 60
Arizono, Y., Yoshikawa, H., Naganuma, H., Hamada, Y., Nakajima, Y., & Tasaka, K. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600666 · Cited by 52
Hotta, T., Suzuki, H., Nagai, S., Yamamoto, K., Imakiire, A., Takada, E., Itoh, M., & Mizuguchi, J. (2003) · Journal of Orthopaedic Research® · doi:10.1016/s0736-0266(03)00062-7 · Cited by 42
Jones, D. T., GANESHAGURU, K., Mitchell, W. A., Foroni, L., Baker, R. J., Prentice, H. G., Mehta, A. B., & Wickremasinghe, R. G. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04340.x · Cited by 30
Miao, L., Peng, Y., Wang, Y., & Wu, M. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03639.x · Cited by 25
Cited by
Promoting apoptosis as a strategy for cancer drug discovery
Fesik, S. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1736 · Cited by 1,098
Wagner, K. W., Punnoose, E. A., Januario, T., Lawrence, D. A., Pitti, R. M., Lancaster, K., Lee, D., von Goetz, M., Yee, S. F., Totpal, K., et al. (2007) · Nature Medicine · doi:10.1038/nm1627 · Cited by 612
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells
Nebbioso, A., Clarke, N., Voltz, E., Germain, E., Ambrosino, C., Bontempo, P., Alvarez, R., Schiavone, E. M., Ferrara, F., Bresciani, F., et al. (2005) · Nature Medicine · doi:10.1038/nm1161 · Cited by 610
Chemotherapeutic Approaches for Targeting Cell Death Pathways
Ricci, M. S., & Zong, W.-X. (2006) · The Oncologist · doi:10.1634/theoncologist.11-4-342 · Cited by 515
Jares, P., Colomer, D., & Campo, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2230 · Cited by 466
Metadata
- Authors
- KELLEY, S.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 4
- Issue
- 4
- Pages
- 333-339
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W2090443758
- Cited by
- 370
- References
- 48
- FWCI
- 11.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.